Pharmaceutical guanidine preparations and methods of using same
US3976787A · kind A · utility
47Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 6, 1975 |
| Grant date | Aug 24, 1976 |
| Priority date | — |
| Expiry date | Mar 6, 1995 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C279/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Pharmaceutical preparations and methods of using the same to treat a host having a condition requiring vasoconstrictive therapy. The preparations comprise a pharmaceutically acceptable carrier and a guanidine compound, or non-toxic acid addition salt thereof, having the structural notation: ##SPC1## Wherein: R.sub.1 is hydrogen or alkyl having 1-4 carbon atoms; R.sub.2 is hydrogen, hydroxy, chloro, fluoro or bromo; and R.sub.3 is hydrogen or the same as R.sub.2 when R.sub.2 is chloro, bromo or fluoro.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.